Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer

被引：11
|
作者：
Zhang, Qiangsheng [1 ,2 ,3 ]
Hu, Xi [1 ,2 ,3 ]
Wan, Guoquan [1 ,2 ,3 ]
Wang, Jia [1 ,2 ,3 ]
Li, Lu [1 ,2 ,3 ]
Wu, Xiuli [1 ,2 ,3 ]
Liu, Zhihao [1 ,2 ,3 ]
Yu, Luoting [1 ,2 ,3 ]
机构：
[1] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Med Sch, West China Hosp, Canc Ctr, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2019年 / 184卷
关键词：
Microtubule; Tubulin polymerization inhibitors; Anti-cancer agents; Colorectal carcinoma; BIOLOGICAL EVALUATION; CELL-GROWTH; POTENT; DESIGN; ANALOGS; TARGET; IDENTIFICATION; MICROTUBULES; RESISTANCE; PURINES;
D O I：
10.1016/j.ejmech.2019.111728
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new series of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives were designed, synthesized and demonstrated to act as tubulin polymerization inhibitors. These new derivatives showed significant antitumor activities, among which SKLB0533 demonstrated to be the most potent compound, with IC50 values ranging from 44.5 to 135.5 nM against seven colorectal carcinoma (CRC) cell lines. Remarkably, SKLB0533 exhibited no activity against other potential targets, such as 420 kinases and EZH2. Besides, SKLB0533 inhibited tubulin polymerization, arrested the cell cycle at the G2/M phase and induced apoptosis in CRC cells. Furthermore, SKLB0533 suppressed tumour growth in the HCT116 xenograft model without inducing notable major organ-related toxicity, suggesting that SKLB0533 could be used as a promising lead compound for the development of new antitumor agents. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：16
相关论文
共 50 条
  • [31] Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors
    Lin, Songwen
    Han, Fangbin
    Liu, Peng
    Tao, Jing
    Zhong, Xuechao
    Liu, Xiujie
    Yi, Chongqin
    Xu, Heng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (03) : 790 - 793
  • [32] 3-(1-Phenyl-4-((2-(4-arylthiazol-2-yl)hydrazono)-methyl)-1H-pyrazol-3-yl)-2H-chromen-2-ones: one-pot three component condensation, in vitro antimicrobial, antioxidant and molecular docking studies
    Gondru, Ramesh
    Banothu, Janardhan
    Thatipamula, Ranjith Kumar
    Hussain, Althaf S. K.
    Bavantulea, Rajitha
    RSC ADVANCES, 2015, 5 (42) : 33562 - 33569
  • [33] Discovery of ( ±)-3-(1H-pyrazol-1-yl)-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4] thiadiazine derivatives with promising in vitro anticoronavirus and antitumoral activity
    Jilloju, Parameshwara Chary
    Persoons, Leentje
    Kurapati, Sathish Kumar
    Schols, Dominique
    De Jonghe, Steven
    Daelemans, Dirk
    Vedula, Rajeswar Rao
    MOLECULAR DIVERSITY, 2022, 26 (03) : 1357 - 1371
  • [34] Novel Synthesis of 4-Benzylidene-2-((1-phenyl-3,4-dihydroisoquinoline-2(1H)-yl)methyl)oxazol-5(4H)-one Derivatives Using 1,2,3,Tetrahydroisoquinoline and their Antimicrobial Activity
    Rao, Nalla Krishna
    Rao, Tentu Nageswara
    Parvatamma, Botsa
    Prashanthi, Y.
    Cheedarala, Ravi Kumar
    CURRENT ORGANIC SYNTHESIS, 2020, 17 (05) : 396 - 403
  • [35] The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors
    Wang, Hui-Ling
    Cee, Victor J.
    Chavez, Frank, Jr.
    Lanman, Brian A.
    Reed, Anthony B.
    Wu, Bin
    Guerrero, Nadia
    Lipford, J. Russell
    Sastri, Christine
    Winston, Jeff
    Andrews, Kristin L.
    Huang, Xin
    Lee, Matthew R.
    Mohr, Christopher
    Xu, Yang
    Zhou, Yihong
    Tasker, Andrew S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (04) : 834 - 840
  • [36] Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1
    Liu, Zhiguo
    Yu, Shufang
    Chen, Di
    Shen, Guoliang
    Wang, Yu
    Hou, Leping
    Lin, Dan
    Zhang, Jinsan
    Ye, Faqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1489 - 1500
  • [37] 3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma
    Cascioferro, Stella
    Li Petri, Giovanna
    Parrino, Barbara
    El Hassouni, Btissame
    Carbone, Daniela
    Arizza, Vincenzo
    Perricone, Ugo
    Padova, Alessandro
    Funel, Niccola
    Peters, Godefridus J.
    Cirrincione, Girolamo
    Giovannetti, Elisa
    Diana, Patrizia
    MOLECULES, 2020, 25 (02):
  • [38] Synthesis of Novel 3-(5-(Alkyl/arylthio)-1,3,4-Oxadiazol-2-yl)-8-Phenylquinolin-4(1H)-One Derivatives as Anti-HIV Agents
    Parizadeh, Niloofar
    Alipour, Eskandar
    Soleymani, Sepehr
    Zabihollahi, Rezvan
    Aghasadeghi, Mohammad Reza
    Hajimahdi, Zahra
    Zarghi, Afshin
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2018, 193 (04) : 225 - 231
  • [39] One pot, three-component synthesis of novel 3, 4-dihydrophthalazin-2(1H)-yl-4-phenyl-4H-pyrans
    Kumar, P. Praveen
    Reddy, Y. Dathu
    Reddy, Ch. Venkata Ramana
    Devi, B. Rama
    Dubey, P. K.
    TETRAHEDRON LETTERS, 2014, 55 (14) : 2177 - 2182
  • [40] Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent D-Amino Acid Oxidase (DAAO) Inhibitors
    Duplantier, Allen J.
    Becker, Stacey L.
    Bohanon, Michael J.
    Borzilleri, Kris A.
    Chrunyk, Boris A.
    Downs, James T.
    Hu, Lain-Yen
    El-Kattan, Ayman
    James, Larry C.
    Liu, Shenping
    Lu, Jiemin
    Maklad, Noha
    Mansour, Mahmoud N.
    Mente, Scot
    Piotrowski, Mary A.
    Sakya, Subas M.
    Sheehan, Susan
    Steyn, Stefanus J.
    Strick, Christine A.
    Williams, Victoria A.
    Zhang, Lei
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3576 - 3585
12345